Method for detecting telomere signals in tumor cells

By using RNase A, RNase H and pepsin treatment, pre-hybridization and high-temperature hybridization, low-temperature annealing and gradient cleaning in tumor cells, the problem of high signal-to-noise ratio of existing telomeres hybridization schemes is solved, and more stable and Accurate telomere signal detection improves the reliability of clinical tests.

CN119061143AInactive Publication Date: 2024-12-03WEST CHINA HOSPITAL SICHUAN UNIV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411301853.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing telomer hybridization protocols have a high signal-to-noise ratio when detecting telomer signal in tumor cells, resulting in adversely affecting stable and precise clinical testing.

Method used

Preparation and pretreatment with tumor cell crawlers, including RNase A and RNase H treatments to remove RNA and RNA-DNA complexes, pepsin treatment removes protein layers on the cell surface, followed by pre-hybridization and high-temperature hybridization, combining low-temperature annealing and gradients Wash and finally observe the co-localization of telomerular ALT signal and nuclear signal through staining.

Benefits of technology

Improve the stability and accuracy of telomere signal detection, enhance the sensitivity of cells to stains, reduce non-specific binding, ensure the specificity and signal strength of hybridization reactions, and provide high-quality telomere signals of tumor cells. judge.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061143A_ABST
    Figure CN119061143A_ABST
Patent Text Reader

Abstract

The invention discloses a method for detecting telomere signals in tumor cells, and belongs to the technical field of telomere signal detection. The detection method comprises the following steps: (1) preparation and pretreatment of a tumor cell slide; (2) pre-hybridization; (3) hybridizing; (4) low-temperature annealing; and (5) cleaning, dyeing and observing. An original telomere in-situ hybridization (telomere FISH) detection method is optimized, nuclease RNase is added on the basis of an original experiment to treat cells, a pre-hybridization solution is designed to pre-hybridize and treat a cell slide, denaturation time is prolonged, hybridization time of a probe and telomere DNA is prolonged, and treatment temperature is adjusted, so that a detection scheme is more stable and reliable; the detection technology can help clinically carry out high-quality and stable tumor cell telomere signal judgment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of telomere signal detection, and in particular to a method for detecting telomere signals in tumor cells. Background Art

[0002] Most tumor cells that extend telomeres using the alternative lengthening of telomeres (ALT) pathway have ATRX gene mutations. Today, cells known to have ATRX mutations include gliomas (mainly glioblastomas, diffuse anaplastic astrocytomas, etc.), pancreatic neuroendocrine tumors, osteosarcomas, and soft tissue sarcomas. In the past, the classification of tumors was mainly based on histological diagnosis, that is, the traditional diagnostic model, including morphological detection under H&E staining, subcellular detection of ultrastructure under electron microscopy, and immunohistochemical detection. At present, histological testing alone is not enough to provide information for clinical treatment, because histological testing may not provide clear clinical treatment guidance, nor may it provide clear evaluation indicators for prognosis. Therefore, the diagnosis of brain tumors or nerve-related tumors must be combined with molecular biological diagnosis, which is the so-called integrated diagnosis.

[0003] At present, the main method for detecting telomere signals in ATRX-related tumors is telomere in situ hybridization (FISH), but the existing telomere hybridization scheme has a high signal-to-noise ratio, which is not conducive to stable and accurate clinical testing. Therefore, it is very meaningful to construct an accurate and stable method for detecting telomere signals in tumor cells. Summary of the invention

[0004] In order to solve the above-mentioned deficiencies in the prior art, the purpose of the present invention is to provide a method for detecting telomere signals in tumor cells to solve the problem that the existing telomere hybridization scheme has a high signal-to-noise ratio and is not conducive to stable and accurate clinical testing.

[0005] The technical solution of the present invention to solve the above technical problem is as follows: a method for detecting telomere signals in tumor cells is provided, comprising the following steps: (1) Preparation and pretreatment of tumor cell slides preparing a tumor cell slide, then treating the tumor cell slide with RNase A and RNase H in sequence, then treating the tumor cell slide with pepsin, and finally washing, dehydrating and drying to obtain a pretreated tumor cell slide; (2) Prehybridization Preheat the pretreated tumor cell slide and prehybridization solution at 40-45°C for 4-6 minutes, then drop the preheated prehybridization solution on the preheated pretreated tumor cell slide, and prehybridize at 40-45°C for 25-35 minutes; (3) Hybridization Preheat the pre-hybridized tumor cell slide and the hybridization solution with probe at 80-90°C for 4-6 minutes, then drop the pre-heated hybridization solution on the pre-heated tumor cell slide and perform hybridization reaction at 80-90°C for 8-12 minutes; (4) Low temperature annealing Take out the hybridized tumor cell slide, cool it naturally to room temperature, and then react at 2-4℃ overnight; (5) The tumor cell slides after low-temperature annealing were washed by gradient washing method, and then the cell nuclei were stained. Finally, the co-localization of telomere ALT signal and cell nuclear signal was observed.

[0006] The beneficial effects of the present invention are as follows: tumor cells are cultured and fixed on a glass slide to prepare a tumor cell slide for later processing. RNase A is an enzyme that can specifically degrade single-stranded RNA. In the tumor cell slide treatment, RNaseA is used to remove RNA in the cell to reduce the interference of RNA with subsequent experiments such as hybridization experiments. RNase H is an enzyme that can specifically degrade RNA chains in DNA-RNA hybrid double strands. In the tumor cell slide treatment, the use of RNase H can remove RNA-DNA complexes and reduce interference with subsequent experiments. Pepsin is a digestive enzyme that can decompose proteins, including proteins on the cell surface. After the tumor cell slide is treated with RNase A and RNase H, continuing to treat with pepsin can remove the protein layer on the cell surface, including receptors and adhesion molecules on the cell membrane. This treatment process helps to enhance the sensitivity of cells to foreign molecules such as dyes and improve the efficiency and specificity of experiments such as in situ hybridization.

[0007] After the tumor cell slides are treated with pepsin, they are then washed, dehydrated, and dried. The washing step is used to remove enzymes and other chemicals remaining in the treatment process to prevent them from interfering with subsequent experiments. Dehydration is to gradually increase the concentration of the solvent to replace the water in the cells in preparation for the subsequent drying step. Drying is to remove the water in the cell slides to maintain the morphology and structure of the cells for subsequent observation.

[0008] During the pre-hybridization process, the pre-treated tumor cell slides and pre-hybridization solution are preheated to ensure that all components are at the same temperature at the beginning of the reaction to reduce the impact of temperature differences on the pre-hybridization efficiency. The purpose of pre-hybridization is to block non-specific nucleic acid binding sites on the tumor cell slides and reduce the non-specific binding of probes to these sites during subsequent hybridization. This process helps to improve the specificity and signal strength of hybridization.

[0009] After pre-hybridization, the hybridization process is carried out. At high temperature, the probe binds to the target nucleic acid sequence in the tumor cells through the principle of base complementary pairing to form a stable hybrid double strand. This reaction is highly specific because a stable hybrid can only be formed when the base sequence of the probe and the target sequence is completely matched.

[0010] After hybridization, the hybridized tumor cell slide is taken out and naturally cooled to room temperature. This process ensures that the hybrid double strand is stably formed at a lower temperature and reduces the occurrence of non-specific hybridization. In the present invention, in particular, a step of reacting overnight at 2-4°C is added, which can ensure that the hybridization reaction is fully carried out and improve the efficiency and specificity of hybridization.

[0011] After low-temperature annealing, the tumor cell slides are then washed with a series of washing solutions of different concentrations. This process is designed to remove unbound probes and other non-specifically bound molecules while maintaining the stability of the hybrid double strands. Finally, the hybrid double strands are marked by staining to make them visible under a microscope. By observation, the presence and location of the target nucleic acid sequence can be detected.

[0012] On the basis of the above technical solution, the present invention can also be improved as follows: Furthermore, in step (1), the concentration of RNase A when treating tumor cells crawling on the slide is 180-220 μg / ml, the treatment temperature is 35-40°C, and the treatment time is 50-70 min; preferably, the concentration of RNase A when treating tumor cells crawling on the slide is 200 μg / ml, the treatment temperature is 37°C, and the treatment time is 60 min.

[0013] Furthermore, in step (1), the concentration of RNase H in treating tumor cells on the slide is 0.04-0.06 units / ml, the treatment temperature is 35-40°C, and the treatment time is 50-70 minutes; preferably, the concentration of RNase H in treating tumor cells on the slide is 0.05 units / ml, the treatment temperature is 37°C, and the treatment time is 60 minutes. Among them, 1 unit refers to the amount of enzyme required to hydrolyze 20pmol of fluorescently labeled 50bp RNA-DNA hybrid chain to generate 1 nmol of nucleotide in 50µl reaction system at 37°C for 20 minutes.

[0014] Furthermore, in step (1), the final concentration of pepsin when treating the tumor cells on the slide is 0.003-0.006wt%, the treatment temperature is 35-40°C, and the treatment time is 4-6min; preferably, the final concentration of pepsin when treating the tumor cells on the slide is 0.005wt%, the treatment temperature is 37°C, and the treatment time is 5min. When treating the tumor cells on the slide with pepsin, pepsin is dissolved in 10mM hydrochloric acid to obtain a pepsin solution of corresponding concentration.

[0015] Furthermore, in step (2), the preheating temperature is 42° C. and the preheating time is 5 min; the prehybridization temperature is 42° C. and the prehybridization time is 30 min.

[0016] Furthermore, the prehybridization solution in step (2) includes the following components at final concentrations: 50 wt % formamide, 4×SSC, 0.1 μg / ml salmon sperm DNA, and 0.1 wt % NP-40 (ethylphenyl polyethylene glycol).

[0017] Furthermore, in step (3), the preheating temperature is 85°C and the preheating time is 5 min; the hybridization temperature is 85°C and the hybridization time is 10 min.

[0018] Furthermore, in step (3), the sequence of the probe is repeated TAACCC, and the number of TAACCC repetitions is ≥5; preferably, the 3' end of the probe is labeled with a FAM fluorescent group, and the number of TAACCC repetitions is preferably 5.

[0019] Furthermore, in step (3), the hybridization solution includes the following components at final concentrations: 20 mM Na2HPO4 (pH 7.2), 20 mM Tris (pH 7.2), 60 wt% formamide, 2×SSC, and 0.1 μg / ml salmon sperm DNA; the hybridization solution also includes a probe at a final concentration of 200 mM.

[0020] Furthermore, the gradient washing method in step (5) is conventional gradient washing, such as using three washing solutions for washing in sequence: washing buffer 1 is NP-40 diluted with 2×SSC solution to a NP-40 concentration of 0.1wt%, washing buffer 2 is NP-40 diluted with 2×SSC solution to a NP-40 concentration of 0.5wt%, and the third washing solution is sterile deionized water.

[0021] The staining in step (5) is to stain and seal the cells using an anti-fluorescence quenching sealing medium containing the cell nuclear dye DAPI.

[0022] Furthermore, the tumor cells are glioma cells, pancreatic neuroendocrine tumor cells, osteosarcoma cells and soft tissue sarcoma cells, but are not limited to these types of cells.

[0023] The present invention has the following beneficial effects: At present, the main method for detecting telomere signals in ATRX-related tumors is telomere in situ hybridization (FISH). The existing telomere hybridization scheme has a high signal-to-noise ratio, which is not conducive to stable and accurate clinical testing. The present invention optimizes the original telomere in situ hybridization (telomere FISH) detection method, adds nuclease RNaseH to treat cells on the basis of the original experiment, designs pre-hybridization solution for pre-hybridization treatment of cell slides, prolongs the denaturation time, prolongs the hybridization time between the probe and telomere DNA, and adjusts the processing temperature to make the detection scheme more stable and reliable. This detection technology can help clinically make high-quality and stable judgments on tumor cell telomere signals. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is the telomere signal result of human glioblastoma U118 in Example 1.

[0025] Figure 2 This is the telomere signal result of human glioma U251 in Example 1.

[0026] Figure 3 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in Example 1.

[0027] Figure 4 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in comparative example 1.

[0028] Figure 5 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in comparative example 2.

[0029] Figure 6 This is the telomere signal result of the pancreatic neuroendocrine tumor cell 093R in comparative example 3. DETAILED DESCRIPTION

[0030] The main reagents and their sources used in the present invention are shown in Table 1: Table 1 Main reagents and sources

[0031] The following examples are only used to explain the present invention and are not intended to limit the scope of the present invention. If no specific conditions are specified in the examples, the conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0032] Embodiment 1: A method for detecting telomere ALT signals in glioblastoma / pancreatic neuroendocrine tumor cells, comprising the following steps in sequence: (1) Place an 18 mm glass cell slide in a 12-well plate, inoculate tumor cell samples (human astrocytoblastoma U118, human glioma U251, and pancreatic neuroendocrine tumor cell 093R) on the cell slide, and observe the cell growth conjugation degree to reach 50-70% under an optical microscope. Wash with PBS to remove cells that are not fixed on the slide, and then fix them with 4% tissue fixative at 4°C overnight.

[0033] (2) Remove the tissue fixative from the cell slide and wash twice with sterile PBS buffer, 2 min each time.

[0034] (3) Dilute the RNase A working solution (the original stock solution concentration is 100 mg / mL) with 2×SSC buffer solution to a final RNase A concentration of 200 μg / ml. Add 300 μl of RNase A working solution to each well and incubate at 37°C for 1 h.

[0035] (4) Remove the RNase A working solution and wash the cell slide once with PBS buffer for 5 minutes.

[0036] (5) Remove the PBS buffer solution and wash the cell slide once with 1×SSC buffer solution for 5 minutes.

[0037] (6) Remove the 1× SSC buffer solution and wash the cell slide once with sterile deionized water for 5 minutes.

[0038] (7) Remove the sterile deionized water and add 200 μl of RNase H working solution with an effective concentration of 0.05 units / ml to the well plate containing the cell slides and incubate at 37°C for 1 h.

[0039] (8) Remove the RNase H working solution and wash the cell slide once with 2×SSC buffer solution for 5 minutes.

[0040] (9) Remove the 2× SSC buffer solution, add pepsin at a final concentration of 0.005 wt %, and react at 37 °C for 5 min.

[0041] (10) Remove pepsin and wash the slides in 500 μl of PBS buffer twice, 5 min each time.

[0042] (11) Immerse the cell slide in 70% ethanol solution for 2 min.

[0043] (12) Immerse the cell slide in 85% ethanol solution for 2 min.

[0044] (13) Immerse the cell slide in 100% ethanol solution for 2 min.

[0045] (14) Let the stem cells climb the slide for 5 minutes.

[0046] (15) Place the cell slide and pre-hybridization solution in a 42°C oven and preheat for 5 min. Then, add the pre-hybridization solution to the cell slide and place it at 42°C for 30 min. The formula of the pre-hybridization solution is: formamide with a final concentration of 50 wt%, 4×SSC, 0.1 μg / ml salmon sperm DNA, and NP-40 with a final concentration of 0.1 wt%.

[0047] (16) Remove the pre-hybridization solution and set the oven temperature to 85°C. When the temperature reaches 85°C, add the hybridization solution with probe and cell slides and heat for 5 minutes. Then, drop the hybridization solution onto the cell slides and react for 10 minutes. The probe is a peptide nucleic acid (PNA) probe sequence labeled with carboxyfluorescein (FAM), the sequence of the PNA probe is repeated TAACCC, the number of repetitions of TAACCC is equal to 5, that is, TAACCCTAACCCTAACCCTAACCCTAACCC, and the last base analog on the PNA sequence (3' end) carries a fluorescent modification (FAM); The formula of the hybridization solution is: 20mM Na2HPO4 (pH7.2), 20mM Tris (pH 7.2), formamide with a final concentration of 60wt%, 2×SSC, and 0.1μg / ml salmon sperm DNA; the concentration of the probe in the hybridization solution with the probe is 200mM.

[0048] (17) The sample was removed from 85°C and placed in a room temperature environment. After cooling to room temperature, it was immediately placed in a 4°C refrigerator to react overnight.

[0049] (18) Remove the hybridization solution on the cell slide, heat the washing buffer 1 to 55°C, and wash the cell slide twice, 5 min each time; wherein, the washing buffer 1 is 0.1% NP-40 / 2×SSC.

[0050] (19) The cell slides were washed once with washing buffer 1 at room temperature for 1 min. Washing buffer 1 was prepared by diluting NP-40 with 2×SSC solution to a concentration of 0.1 wt %.

[0051] (20) The washing buffer 2 was heated to 5°C and the cell slides were washed twice, 5 min each time; wherein, the washing buffer 2 was prepared by diluting NP-40 with 2×SSC solution to a concentration of 0.5 wt %.

[0052] (21) The cell slides were washed once with washing buffer 2 at room temperature for 1 min. Washing buffer 2 was prepared by diluting NP-40 with 2×SSC solution to a concentration of 0.5 wt %.

[0053] (22) Wash the cell slide once with sterile deionized water at room temperature for 1 min.

[0054] (23) Allow the surface of the cell slide to air dry at room temperature.

[0055] (24) The cells were stained and sealed with an anti-fluorescence quenching sealing medium containing the nuclear dye DAPI. The amount of sealing medium used was 6-8 μl.

[0056] (25) The cell slides were imaged using the Andor Dragonfly 200 spinning disk confocal microscope system, and post-processed using the ImarisViewer software control.

[0057] (26) ALT test results.

[0058] Comparative Example 1: The tumor cells used in Comparative Example 1 are pancreatic neuroendocrine tumor cells 093R. The difference between Comparative Example 1 and Example 1 is that only RNaseA is added, RNaseH is not used, and no pre-hybridization treatment is performed. The rest is the same as Example 1.

[0059] Comparative Example 2: The tumor cells used in Comparative Example 2 are pancreatic neuroendocrine tumor cells 093R. The difference between Comparative Example 2 and Example 1 is that RNaseA and RNaseH are not added, and no pre-hybridization treatment is performed. The rest is the same as Example 1.

[0060] Comparative Example 3: The tumor cells used in Comparative Example 3 are pancreatic neuroendocrine tumor cells 093R. The difference between Comparative Example 3 and Example 1 is that step (17) is not carried out at 4° C. overnight. The rest is the same as Example 1.

[0061] The results of the telomere signal of tumor cells detected by the methods of Example 1 and Comparative Examples 1-3 are shown in Figure 1-6 ;in, Figure 1 This is the telomere signal result of human astrocytic glioblastoma U118 in Example 1; Figure 2 This is the telomere signal result of human glioma U251 in Example 1; Figure 3 The telomere signal results of pancreatic neuroendocrine tumor cell 093R in Example 1; Figure 4 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in comparative example 1; Figure 5 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in comparative example 2; Figure 6 This is the telomere signal result of pancreatic neuroendocrine tumor cell 093R in comparative example 3.

[0062] Depend on Figure 1-3 It can be seen that during the detection process, the digestion steps of RNaseA and RNaseH were added, and pre-hybridization treatment was performed. The cell nucleus and telomere staining signals were strong, and the telomere signals of tumor cells could be clearly detected.

[0063] Figure 4 In the experiment, the overall telomere signal in the cells was weak. Figure 5 In the experiment, not only the overall telomere signal inside the cell is weak, but also there are many extracellular miscellaneous signals. Figure 6 In the experiment, the overall telomere signal in the cells was low.

[0064] From the above results, it can be seen that only by adding the digestion steps of RNaseA and RNaseH and performing pre-hybridization treatment, and in addition, the hybridization process requires overnight at 4°C, can the intracellular telomere staining signal be more effectively detected.

[0065] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for detecting telomere signals in tumor cells, characterized in that: The following steps are involved: (1) Preparation and pretreatment of tumor cell slides preparing a tumor cell slide, then treating the tumor cell slide with RNase A and RNase H in sequence, then treating the tumor cell slide with pepsin, and finally washing, dehydrating and drying to obtain a pretreated tumor cell slide; (2) Prehybridization Preheat the pretreated tumor cell slide and prehybridization solution at 40-45°C for 4-6 minutes, then drop the preheated prehybridization solution on the preheated pretreated tumor cell slide, and prehybridize at 40-45°C for 25-35 minutes; (3) Hybridization Preheat the pre-hybridized tumor cell slide and the hybridization solution with probe at 80-90°C for 4-6 minutes, then drop the pre-heated hybridization solution on the pre-heated tumor cell slide and perform hybridization reaction at 80-90°C for 8-12 minutes; (4) Low temperature annealing Take out the hybridized tumor cell slide, cool it naturally to room temperature, and then react at 2-4℃ overnight; (5) The tumor cell slides after low-temperature annealing were washed by gradient washing method, and then the cell nuclei were stained. Finally, the co-localization of telomere ALT signal and cell nuclear signal was observed.

2. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (1), the concentration of RNase A when treating tumor cells on the slide is 180-220 μg / ml, the treatment temperature is 35-40°C, and the treatment time is 50-70 min.

3. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (1), the concentration of RNase H in treating tumor cells on the slide is 0.04-0.06 units / ml, the treatment temperature is 35-40°C, and the treatment time is 50-70 minutes.

4. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (1), the final concentration of pepsin when treating the tumor cell slides with pepsin is 0.003-0.006 wt %, the treatment temperature is 35-40° C., and the treatment time is 4-6 min.

5. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (2), the preheating temperature is 42°C and the preheating time is 5 min; the prehybridization temperature is 42°C and the prehybridization time is 30 min.

6. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: The prehybridization solution in step (2) includes the following components at final concentrations: 50 wt % formamide, 4×SSC, 0.1 μg / ml salmon sperm DNA, and 0.1 wt % NP-40.

7. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (3), the preheating temperature is 85°C and the preheating time is 5 min; the hybridization temperature is 85°C and the hybridization time is 10 min.

8. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: The sequence of the probe in step (3) is repeated TAACCC, where the number of TAACCC repeats is ≥5.

9. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: In step (3), the hybridization solution includes the following components at final concentrations: Na2HPO4 at pH 7.2 and a concentration of 20 mM, Tris at pH 7.2 and a concentration of 20 mM, 60 wt% formamide, 2×SSC, and 0.1 μg / ml salmon sperm DNA; the hybridization solution also includes a probe at a final concentration of 200 mM.

10. The method for detecting telomere signals in tumor cells according to claim 1, characterized in that: The tumor cells are glioma cells, pancreatic neuroendocrine tumor cells, osteosarcoma cells and soft tissue sarcoma cells.

Citation Information

Patent Citations

  • Compositions and methods for performing hybridizations with separate denaturation of the sample and probe

    CN102369295A

  • Telomere probe and preparation method and application thereof

    CN107723342A

  • Treatment of ALT cancers

    US20230149507A1

  • DNA-fish method for measurement of telomere length

    WO2021025935A1